BioTuesdays

Tag - Marie Thibault

Senseonics
Markets

BTIG cuts Senseonics to neutral from buy; removes PT

BTIG downgraded Senseonics Holdings (NYSE American:SENS) to “neutral” from “buy” and removed its price target, citing Senseonics’ stock price, which has soared about 500% over the past month. The stock closed at $2.67...

January 21, 2021
Delcath-Systems-Inc
Markets

BTIG starts Delcath Systems at buy; PT $23

BTIG initiated coverage of Delcath Systems (NASDAQ:DCTH) with a “buy” rating and price target of $23. The stock closed at $16.91 on Jan. 4. Delcath has developed HEPZATO, a percutaneous hepatic perfusion system that “we...

January 5, 2021
Neuronetics Logo
Markets

BTIG ups Neuronetics PT to $10 from $6

BTIG raised its price target for Neuronetics (NASDAQ:STIM) to $10 from $6, citing takeaways from recent virtual investor meetings, which focused on how the company’s new CEO, Keith Sullivan, will be reshaping the...

October 6, 2020
Endologix Logo
Markets

BTIG cuts Endologix to neutral; removes price target

BTIG downgraded Endologix (NASDAQ:ELGX) to “neutral” without a price target, citing “greater uncertainty” that the potential COVID-19 impact on revenue could put the company’s financial covenants in peril. The stock...

May 12, 2020
Neuronetics Logo
Markets

Analysts cuts Neuronetics PTs citing COVID-19 impact

Analysts for BTIG and Canaccord Genuity slashed their price target for Neuronetics (NASDAQ:STIM) but maintained their “buy” ratings, citing a potential leaner post-pandemic business model. Neuronetics markets the...

April 9, 2020
Senseonics
Markets

BTIG cuts Senseonics to neutral; removes PT

BTIG downgraded Senseonics Holdings (NYSE American:SENS) to “neutral” from “buy” and removed its price target after the company released 2020 sales guidance of $15-million to $20-million, well below the Street’s $37...

March 13, 2020
Endologix Logo
Markets

BTIG halves Endologix PT to $6 from $12

BTIG halved its price target for Endologix (NASDAQ:ELGX) to $6 from $12, but maintained its “buy” rating, saying the new target better reflects the current stock price, which closed at 89 cents on Feb. 19. Endologix...

February 20, 2020
Accuray
Markets

BTIG ups Accuray to buy; PT $9.50

BTIG upgraded Accuray (NASDAQ:ARAY) to “buy” from “neutral,” with a price target of $9.50. The stock closed at $3.28 on Jan. 17. Last week, Accuray announced a compound annual growth rate revenue outlook of 8% to 12%...

January 21, 2020